Detalhe da pesquisa
1.
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
Ann Rheum Dis
; 83(5): 547-549, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071514
2.
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients.
Rheumatol Int
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597981
3.
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Ann Rheum Dis
; 82(1): 130-141, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270657
4.
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Ann Rheum Dis
; 82(2): 212-216, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100350
5.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368906
6.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410794
7.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 107-118, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376026
8.
Instrument selection for the ASAS core outcome set for axial spondyloarthritis.
Ann Rheum Dis
; 82(6): 763-772, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680390
9.
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ann Rheum Dis
; 82(1): 19-34, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270658
10.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
11.
Controversies in rheumatology: telemedicine-friend or foe?
Rheumatology (Oxford)
; 62(8): 2661-2664, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534821
12.
The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study.
Rheumatology (Oxford)
; 62(8): 2700-2706, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538875
13.
Organ involvement and assessment in sarcoidosis.
Curr Opin Pulm Med
; 29(5): 485-492, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461850
14.
Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more.
Br J Clin Pharmacol
; 2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791777
15.
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
Ann Rheum Dis
; 81(3): 422-432, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876462
16.
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Ann Rheum Dis
; 81(6): 780-785, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058229
17.
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
Ann Rheum Dis
; 81(12): 1628-1639, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197264
18.
Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years.
Rheumatology (Oxford)
; 61(12): 4722-4730, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302592
19.
Use of multidimensional composite scores in rheumatology: parsimony versus subtlety.
Ann Rheum Dis
; 80(3): 280-285, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33144304
20.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Ann Rheum Dis
; 80(7): 848-858, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504485